Research advances in the pathogenesis and treatment of metabolic associated fatty liver disease
精准医学杂志 · 2026-04 · 41 (2) · 179-184
DOI: 10.13362/j.jpmed.202641024 ↗Kurz gefasst
Fachartikel in der Zeitschrift 精准医学杂志, 2026-04. Verfasst von LIA-NG Guanyou und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Metabolic associated fatty liver disease (MAFLD) is a chronic liver disease caused by the combined effect of genetic susceptibility, metabolic disorders, gut microbiota dysbiosis, and environmental factors. With the changes in modern lifestyle, the global prevalence rate of MAFLD has reached approximately 38%, making it a major public health issue. Although recent studies have made significant breakthroughs in the pathogenesis of MAFLD such as insulin resistance, dyslipidemia, abnormal inflammatory signaling pathways, and gut microbiota imbalance and have identified potential therapeutic targets such as glucagon-like peptide-1 and farnesoid X receptor, there is still a lack of specific therapeutic drugs in clinical practice. Lifestyle intervention is the main standard therapy for MAFLD, and although surgical treatment has unique advantages, it is also associated with the issues such as surgical risks and postoperative complications; therefore, there is an urgent need to explore precise treatment strategies. This article systematically reviews the research advances in the pathogenesis and treatment of MAFLD, in order to provide a theoretical basis for developing individualized treatment regimens for MAFLD.
Schlagwörter
Zitieren
APA
Guanyou, L., Shuo, Z., Xinling, C., SHADIK·Apar, & Tao, L. (2026). Research advances in the pathogenesis and treatment of metabolic associated fatty liver disease. 精准医学杂志, 41(2), 179-184. https://doi.org/10.13362/j.jpmed.202641024
Vancouver
Guanyou L, Shuo Z, Xinling C, SHADIK·Apar, Tao L. Research advances in the pathogenesis and treatment of metabolic associated fatty liver disease. 精准医学杂志. 2026;41(2):179-184. doi:10.13362/j.jpmed.202641024
BibTeX
@article{Guanyou2026,
author = {Guanyou, LIA-NG and Shuo, ZHANG and Xinling, CAO and SHADIK·Apar and Tao, LI},
title = {Research advances in the pathogenesis and treatment of metabolic associated fatty liver disease},
journal = {精准医学杂志},
year = {2026},
volume = {41},
number = {2},
pages = {179--184},
doi = {10.13362/j.jpmed.202641024}
}
EUVIMED